Winfield Associates’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-55
Closed -$2K 174
2017
Q4
$2K Sell
55
-25
-31% -$396 ﹤0.01% 645
2017
Q3
$1K Sell
80
-5
-6% -$76 ﹤0.01% 664
2017
Q2
$1K Sell
85
-5
-6% -$60 ﹤0.01% 752
2017
Q1
$1K Hold
90
﹤0.01% 642
2016
Q4
$1K Buy
90
+20
+29% +$367 ﹤0.01% 606
2016
Q3
$2K Sell
70
-5
-7% -$129 ﹤0.01% 524
2016
Q2
$2K Sell
75
-5
-6% -$142 ﹤0.01% 516
2016
Q1
$2K Buy
+80
New +$5.92K ﹤0.01% 477

Other funds holding BHC

Winfield Associates's BHC Position: Q1 2018 in Review

Winfield Associates sold out of Bausch Health (BHC) in Q1 2018, closing a stake of 55 shares — an estimated $2K sold.

Winfield Associates first reported a position in BHC in Q1 2016 and held it in 8 quarters. The position peaked at $2K in Q4 2017. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2018.

  • Winfield Associates reported no remaining Bausch Health position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 55 Bausch Health shares in Q1 2018, an estimated $2K.
  • Winfield Associates first reported a position in Bausch Health in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Bausch Health position peaked at $2K in Q4 2017.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.